News
Latest news
![](https://katacanada.org/wp-content/uploads/2021/10/KATA_Icon.png)
Stay up to date on the latest news for ketamine regulatory requirements, practice recommendations, developments in ketamine research, and updates and information affecting the delivery of ketamine assisted therapy in Canada.
Ketamine’s History as a Useful Medicine and a Therapeutic Tool for Mental Health Conditions
Ketamine is an N-methyl-d-aspartate receptor antagonist and glutamatergic modulator.
Read MoreCanada’s Ketamine Association Releases Recommendations for Practice Standards
Guideline for Safe and Accessible Treatment
Read MoreKetamine Practice Survey Live
Until October 21st KATA Canada is collecting responses in the...
Read MoreKATA Canada Announcing Ketamine for Mental Health Conditions Practice Survey
KATA Canada has created the Ketamine for Mental Health Conditions...
Read MoreThe Importance Of Ethical Guidelines For Ketamine Assisted Therapy
Our Blog The Importance Of Ethical Guidelines For Ketamine Assisted...
Read MoreNew Study Shows Safe Levels Of Ketamine In Breast Milk
A recently published study The Pharmacokinetics of Ketamine in the...
Read MoreJob Posting: Executive Director Administrative Assistant – Job Filled!
Our Blog JOB POSTING: EXECUTIVE DIRECTOR ADMINISTRATIVE ASSISTANT – Job...
Read MoreKata Canada Announces New Executive Director
Our Blog Kata Canada Announces New Executive Director KATA Canada...
Read MoreKata Canada Announces New Executive Director-old
KATA Canada is pleased to announce that the Board has...
Read More